<?xml version='1.0' encoding='utf-8'?>
<document id="28527109"><sentence text="Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor."><entity charOffset="41-51" id="DDI-PubMed.28527109.s1.e0" text="Sacubitril" /><entity charOffset="52-61" id="DDI-PubMed.28527109.s1.e1" text="Valsartan" /><entity charOffset="80-91" id="DDI-PubMed.28527109.s1.e2" text="Angiotensin" /><pair ddi="false" e1="DDI-PubMed.28527109.s1.e0" e2="DDI-PubMed.28527109.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s1.e0" e2="DDI-PubMed.28527109.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s1.e0" e2="DDI-PubMed.28527109.s1.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s1.e1" e2="DDI-PubMed.28527109.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s1.e1" e2="DDI-PubMed.28527109.s1.e2" /></sentence><sentence text="Sacubitril/valsartan (LCZ696) is indicated for the treatment of heart failure with reduced ejection fraction"><entity charOffset="0-10" id="DDI-PubMed.28527109.s2.e0" text="Sacubitril" /><entity charOffset="11-20" id="DDI-PubMed.28527109.s2.e1" text="valsartan" /><entity charOffset="22-28" id="DDI-PubMed.28527109.s2.e2" text="LCZ696" /><pair ddi="false" e1="DDI-PubMed.28527109.s2.e0" e2="DDI-PubMed.28527109.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s2.e0" e2="DDI-PubMed.28527109.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s2.e0" e2="DDI-PubMed.28527109.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s2.e1" e2="DDI-PubMed.28527109.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s2.e1" e2="DDI-PubMed.28527109.s2.e2" /></sentence><sentence text=" Absorption of sacubitril/valsartan and conversion of sacubitril (prodrug) to sacubitrilat (neprilysin inhibitor) was rapid with maximum plasma concentrations of sacubitril, sacubitrilat, and valsartan (angiotensin receptor blocker) reaching within 0"><entity charOffset="15-25" id="DDI-PubMed.28527109.s3.e0" text="sacubitril" /><entity charOffset="26-35" id="DDI-PubMed.28527109.s3.e1" text="valsartan" /><entity charOffset="54-64" id="DDI-PubMed.28527109.s3.e2" text="sacubitril" /><entity charOffset="162-172" id="DDI-PubMed.28527109.s3.e3" text="sacubitril" /><entity charOffset="174-186" id="DDI-PubMed.28527109.s3.e4" text="sacubitrilat" /><entity charOffset="192-201" id="DDI-PubMed.28527109.s3.e5" text="valsartan" /><entity charOffset="203-214" id="DDI-PubMed.28527109.s3.e6" text="angiotensin" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e0" e2="DDI-PubMed.28527109.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e1" e2="DDI-PubMed.28527109.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e2" e2="DDI-PubMed.28527109.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e2" e2="DDI-PubMed.28527109.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e2" e2="DDI-PubMed.28527109.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e2" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e2" e2="DDI-PubMed.28527109.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e3" e2="DDI-PubMed.28527109.s3.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e3" e2="DDI-PubMed.28527109.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e3" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e3" e2="DDI-PubMed.28527109.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e4" e2="DDI-PubMed.28527109.s3.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e4" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e4" e2="DDI-PubMed.28527109.s3.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e5" e2="DDI-PubMed.28527109.s3.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s3.e5" e2="DDI-PubMed.28527109.s3.e6" /></sentence><sentence text="5, 1" /><sentence text="5-2" /><sentence text="0, and 2" /><sentence text="0-3" /><sentence text="0 h, respectively" /><sentence text=" With a twofold increase in dose, an increase in the area under the plasma concentration-time curve was proportional for sacubitril, ~1"><entity charOffset="121-131" id="DDI-PubMed.28527109.s9.e0" text="sacubitril" /></sentence><sentence text="9-fold for sacubitrilat, and ~1" /><sentence text="7-fold for valsartan in healthy subjects"><entity charOffset="11-20" id="DDI-PubMed.28527109.s11.e0" text="valsartan" /></sentence><sentence text=" Following multiple twice-daily administration, steady-state maximum plasma concentration was reached within 3 days, showing no accumulation for sacubitril and valsartan, while ~1"><entity charOffset="145-155" id="DDI-PubMed.28527109.s12.e0" text="sacubitril" /><entity charOffset="160-169" id="DDI-PubMed.28527109.s12.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.28527109.s12.e0" e2="DDI-PubMed.28527109.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s12.e0" e2="DDI-PubMed.28527109.s12.e1" /></sentence><sentence text="6-fold accumulation for sacubitrilat" /><sentence text=" Sacubitril is eliminated predominantly as sacubitrilat through the kidney; valsartan is eliminated mainly by biliary route"><entity charOffset="76-85" id="DDI-PubMed.28527109.s14.e0" text="valsartan" /></sentence><sentence text=" Drug-drug interactions of sacubitril/valsartan were evaluated with medications commonly used in patients with heart failure including furosemide, warfarin, digoxin, carvedilol, levonorgestrel/ethinyl estradiol combination, amlodipine, omeprazole, hydrochlorothiazide, intravenous nitrates, metformin, statins, and sildenafil"><entity charOffset="27-37" id="DDI-PubMed.28527109.s15.e0" text="sacubitril" /><entity charOffset="38-47" id="DDI-PubMed.28527109.s15.e1" text="valsartan" /><entity charOffset="135-145" id="DDI-PubMed.28527109.s15.e2" text="furosemide" /><entity charOffset="147-155" id="DDI-PubMed.28527109.s15.e3" text="warfarin" /><entity charOffset="157-164" id="DDI-PubMed.28527109.s15.e4" text="digoxin" /><entity charOffset="166-176" id="DDI-PubMed.28527109.s15.e5" text="carvedilol" /><entity charOffset="178-192" id="DDI-PubMed.28527109.s15.e6" text="levonorgestrel" /><entity charOffset="193-210" id="DDI-PubMed.28527109.s15.e7" text="ethinyl estradiol" /><entity charOffset="224-234" id="DDI-PubMed.28527109.s15.e8" text="amlodipine" /><entity charOffset="236-246" id="DDI-PubMed.28527109.s15.e9" text="omeprazole" /><entity charOffset="248-267" id="DDI-PubMed.28527109.s15.e10" text="hydrochlorothiazide" /><entity charOffset="281-289" id="DDI-PubMed.28527109.s15.e11" text="nitrates" /><entity charOffset="291-300" id="DDI-PubMed.28527109.s15.e12" text="metformin" /><entity charOffset="315-325" id="DDI-PubMed.28527109.s15.e13" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e0" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e1" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e2" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e3" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e3" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e4" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e4" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e5" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e5" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e6" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e6" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e7" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e7" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e8" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e8" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e9" e2="DDI-PubMed.28527109.s15.e9" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e9" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e9" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e9" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e9" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e10" e2="DDI-PubMed.28527109.s15.e10" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e10" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e10" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e10" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e11" e2="DDI-PubMed.28527109.s15.e11" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e11" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e11" e2="DDI-PubMed.28527109.s15.e13" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e12" e2="DDI-PubMed.28527109.s15.e12" /><pair ddi="false" e1="DDI-PubMed.28527109.s15.e12" e2="DDI-PubMed.28527109.s15.e13" /></sentence><sentence text=" Co-administration with sacubitril/valsartan increased the maximum plasma concentration (~2"><entity charOffset="24-34" id="DDI-PubMed.28527109.s16.e0" text="sacubitril" /><entity charOffset="35-44" id="DDI-PubMed.28527109.s16.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.28527109.s16.e0" e2="DDI-PubMed.28527109.s16.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s16.e0" e2="DDI-PubMed.28527109.s16.e1" /></sentence><sentence text="0-fold) and area under the plasma concentration-time curve (1" /><sentence text="3-fold) of atorvastatin; however, it did not affect the pharmacokinetics of simvastatin"><entity charOffset="11-23" id="DDI-PubMed.28527109.s18.e0" text="atorvastatin" /><entity charOffset="76-87" id="DDI-PubMed.28527109.s18.e1" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.28527109.s18.e0" e2="DDI-PubMed.28527109.s18.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s18.e0" e2="DDI-PubMed.28527109.s18.e1" /></sentence><sentence text=" Age, sex, or ethnicity did not affect the pharmacokinetics of sacubitril/valsartan"><entity charOffset="63-73" id="DDI-PubMed.28527109.s19.e0" text="sacubitril" /><entity charOffset="74-83" id="DDI-PubMed.28527109.s19.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.28527109.s19.e0" e2="DDI-PubMed.28527109.s19.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s19.e0" e2="DDI-PubMed.28527109.s19.e1" /></sentence><sentence text=" In patients with heart failure vs" /><sentence text=" healthy subjects, area under the plasma concentration-time curves of sacubitril, sacubitrilat, and valsartan were higher by approximately 1"><entity charOffset="70-80" id="DDI-PubMed.28527109.s21.e0" text="sacubitril" /><entity charOffset="82-94" id="DDI-PubMed.28527109.s21.e1" text="sacubitrilat" /><entity charOffset="100-109" id="DDI-PubMed.28527109.s21.e2" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.28527109.s21.e0" e2="DDI-PubMed.28527109.s21.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s21.e0" e2="DDI-PubMed.28527109.s21.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s21.e0" e2="DDI-PubMed.28527109.s21.e2" /><pair ddi="false" e1="DDI-PubMed.28527109.s21.e1" e2="DDI-PubMed.28527109.s21.e1" /><pair ddi="false" e1="DDI-PubMed.28527109.s21.e1" e2="DDI-PubMed.28527109.s21.e2" /></sentence><sentence text="6-, 2" /><sentence text="1-, and 2" /><sentence text="3-fold, respectively" /><sentence text=" Renal impairment had no significant impact on sacubitril and valsartan area under the plasma concentration-time curves, while the area under the plasma concentration-time curve of sacubitrilat correlated with degree of renal function (1"><entity charOffset="47-57" id="DDI-PubMed.28527109.s25.e0" text="sacubitril" /><entity charOffset="62-71" id="DDI-PubMed.28527109.s25.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.28527109.s25.e0" e2="DDI-PubMed.28527109.s25.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s25.e0" e2="DDI-PubMed.28527109.s25.e1" /></sentence><sentence text="3-, 2" /><sentence text="3-, 2" /><sentence text="9-, and 3" /><sentence text="3-fold with mild, moderate, and severe renal impairment, and end-stage renal disease, respectively)" /><sentence text=" Moderate hepatic impairment increased the area under the plasma concentration-time curves of valsartan and sacubitrilat ~2"><entity charOffset="94-103" id="DDI-PubMed.28527109.s30.e0" text="valsartan" /><entity charOffset="108-120" id="DDI-PubMed.28527109.s30.e1" text="sacubitrilat" /><pair ddi="false" e1="DDI-PubMed.28527109.s30.e0" e2="DDI-PubMed.28527109.s30.e0" /><pair ddi="false" e1="DDI-PubMed.28527109.s30.e0" e2="DDI-PubMed.28527109.s30.e1" /></sentence><sentence text="1-fold" /><sentence text="" /></document>